Breast Cancer Mortality among Women with a BRCA1 or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program

SIMPLE SUMMARY: Women with a BRCA1 or BRCA2 gene mutation have up to an 80% lifetime risk of breast cancer unless their breasts are surgically removed, but many decline or defer surgery and choose screening, hoping that if cancer occurs, it will be detected at a curable stage. In this study 489 wome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Warner, Ellen, Zhu, Siqi, Plewes, Donald B., Hill, Kimberley, Ramsay, Elizabeth A., Causer, Petrina A., Seely, Jean, Jong, Roberta A., Lenkov, Pamela, Elser, Christine, Crystal, Pavel, Yaffe, Martin J., Giannakeas, Vasily, Sun, Ping, Narod, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7700272/
https://ncbi.nlm.nih.gov/pubmed/33238387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113479
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados